Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2007-06-15 French Gregory M Director Grant or award · Stock Option (right to buy) +10,000 10,000
2007-06-15 Schutz James J Vice President Grant or award · Stock Option (right to buy) +100,000 100,000
2007-06-15 Thornton Bruce Vice President Grant or award · Stock Option (right to buy) +25,000 25,000
2007-06-15 Wokasch Michael Chief Operating Officer Grant or award · Stock Option (right to buy) +150,001 150,001
2007-04-26 Miller Robert E Chief Financial Officer Returned to the company · Stock Option (right to buy) −60,000 0
2007-04-26 Miller Robert E Chief Financial Officer Grant or award · Restricted Stock Units +60,000 $3.00 $180K 60,000
2007-04-20 Birnbaum Jay E Director Grant or award · Stock Option (right to buy) +50,000 50,000
2007-01-30 French Gregory M Director Purchase +10,000 $7.81 $78K 28,750
2007-01-30 Miller Robert E Chief Financial Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2007-01-30 Conley Richard K Director Conversion +10,000 40,000
2007-01-30 Conley Richard K Director Conversion · Series A Preferred Stock −10,000 0
2007-01-30 Burlingame Robert Director Conversion +66,666 66,666
2007-01-30 Burlingame Robert Director Conversion · Series A Preferred Stock −66,666 0
2007-01-24 Burlingame Robert Director Grant or award · Stock Option (right to buy) +75,000 75,000
2007-01-24 Burlingame Robert Director Returned to the company · Stock Option (right to buy) −75,000 0
2007-01-24 Burlingame Robert Director Grant or award · Warrant (right to buy) +75,000 75,000
2007-01-24 Burlingame Robert Director Returned to the company · Warrant (right to buy) −75,000 0

Page 19 of 19 · 377 trades